Outside of a clinical trial, how do you approach upfront therapy for a PDGFRA D842V-mutant GIST?

These are usually indolent surgical tumors (until they are not) that belong in the care of a sarcoma center and not in the community. There are two trials of agents that are being tested for D842V mutations at this time (NCT02508532 and NCT02847429).